Stock screenerAll disclosures →
EDGAR →
MDGL
Conviction 86HealthcareScan · Thu, Jun 25, 2026MDGL$513.56+0.75%
ResistanceSupportVol 14Insider sell11
Vol MA14 317.07K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price513.56
Change+0.75%
Gap+0.54%
Rel volume2.13×
Avg volume312.84K
Avg $ vol154.36M
SMA 20492.10
SMA 50508.89
SMA 200494.87
Price vs 50+0.92%
Price vs 200+3.78%
MA stackbullish
50/200 cross—
Supertrenddown · 528.14
RSI (14)56
MACD hist4.18
MACD crossbull · 6d
Stoch %K / %D79 / 80
ADX (14)12
+DI / −DI21 / 20
RSI divergence—
MACD divergence—
ATR %+3.75%
ADR %3.91%
52w high602.83
52w low277.64
From 52w high-14.81%
Above 52w low+84.97%
New 52w highNo
SqueezeOff
Bollinger width14.16%
%B0.81
Donchian pos80.75%
Donchian high529.86
Donchian low445.20
AVWAP (52w high)495.90
vs AVWAP high+3.56%
AVWAP (52w low)459.66
vs AVWAP low+11.72%
OBV trendFlat
Chaikin MF (20)-0.13
Today vs 20d2.13×
Avg vol (14d)317.07K
Avg vol (20d)312.84K
Avg $ vol (20d)154.36M
Market cap11.84B
RS 3m (vs SPY)+2.29%
RS 6m (vs SPY)-21.49%
RS line new highNo
Trend template7/8
Technical rank43.5
1 week+2.74%
1 month-2.04%
3 months+11.18%
6 months-14.81%
1 year+80.21%
YTD-13.52%
P/E-41.07
P/B21.79
P/S12.35
P/FCF-62.31
EPS-12.85
Div yield—
ROE-53.05%
ROA-23.49%
Debt/Eq0.63
Current3.50
EV/EBITDA-40.03
Gross margin—
Net margin-30.08%
Rev growth432.05%
EPS growth38.12%
Price target676.73
Target upside31.77%
Analyst ratingBuy
Institutional112.01%
Ent. value11.95B
Revenue311.34M
Net income-94.39M
Gross profit—
Free cash flow-190.02M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out23.06M
Employees915
ListedTue, Feb 6, 2007
Free float16.43M
Float %71.6%
Short interest3.82M
Days to cover14.1d
Short volume32.8%
Squeeze score80 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$2.66 · 5 est
Last EPS vs est−$3.25 vs −$3.61
Last surprise+10.0% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank43.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance553.12
Support453.05
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MDGL
No recent disclosed trades by Congress in MDGL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MDGL · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Daly James M Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
Daly James M Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
BAKER BROS. ADVISORS LP Director · Common Stock · 2026-06-17 | Grant | 908 | — | 2026-06-17 | 2026-06-18 |
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Options (right to buy) · 2026-06-17 | Grant | 1.53K | — | 2026-06-17 | 2026-06-18 |
Brennan Daniel J. Director · Common Stock · 2026-06-17 | Grant | 404 | — | 2026-06-17 | 2026-06-18 |
Brennan Daniel J. Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 681 | — | 2026-06-17 | 2026-06-18 |
FOUSE JACQUALYN A Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
FOUSE JACQUALYN A Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
Levy Richard S Director · Common Stock · 2026-06-17 | Grant | 454 | — | 2026-06-17 | 2026-06-18 |
Levy Richard S Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 766 | — | 2026-06-17 | 2026-06-18 |
SEC filings
EDGAR filings in MDGL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.